Restless Legs Syndrome Market: Technological, Clinical and Commercial Aspects
Global
Restless Legs Syndrome Market: Overview
Restless
legs syndrome, also called Willis-Ekbom disease, is a neurological disorder. It
triggers an urge in patients to move their legs. Because the syndrome usually
occurs during sleep, it is also considered a type of sleep disorder. People
suffering from RLS often feel an overwhelming desire to rigorously move their
legs, due to which they feel an unpleasant pain in their limbs. This eventually
disturbs their sleep patterns, affecting their health adversely. The condition
usually aggravates at night when the patient is at rest.
To
access full report, please visit : http://www.transparencymarketresearch.com/restless-legs-syndrome-market.html
A higher prevalence of RLS
is noted in women than in men. RLS can affect people of all ages but the
syndrome mostly affects middle-aged and elderly people. The most common
symptoms of RLS include uncomfortable itching and pain in the legs that may
cause a disruption in the sleep pattern and ultimately affect a patient’s
quality of life. Despite its increasing prevalence, the precise cause of RLS is
not yet known. Nevertheless, with extensive investigations conducted in the
field, the RLS market is expected to gain momentum in the near future. As of
now, experts attribute genetic factors, instabilities in the dopaminergic
balance, or low levels of iron to the increasing incidence of the syndrome.
While researchers are yet
to discover a specific cure for the disorder, drugs presently available in the
market ensure symptomatic treatment. They help in relieving the uneasiness
commonly experienced in the disorder. The report studies the prospects for the
global restless legs syndrome market in the forthcoming years. The impact of
research and development activities on the market’s future outlook is examined
in the report in detail. It also presents insights into the various social and
economic factors that will influence the market’s growth trajectory between
2016 and 2024.
Global Restless Legs Syndrome Market: Opportunities and Market
Segmentation
Restless legs syndrome
causes uneasiness in patients and is also associated with other health issues
such as dizziness, headaches, drowsiness, flatulence, dry mouth, and nausea.
Psychiatric disorders such as depression and a decreased libido are also faced
by patients suffering from RLS. Apart from these, nutritional and metabolism
disorders, including weight gain, increased appetite, labyrinth disorders, ear
disorders, fatigue, irritability, and peripheral edema are also related to the
syndrome.
The treatment of restless
legs syndrome is still a relatively untapped space. This provides immense
opportunities for the RLS market to tap into. The market is projected to report
growth at an increased rate with the development of new drugs that promise
higher efficiency and minimum side effects.
Based on product type, the
global restless legs syndrome market can be segmented into Neupro/Leganto,
Mirapex/Sifrol/Mirapexin, HORIZANT/Regnite, and Requip. On the basis of disease
type the market can be broadly classified into genetic factors, etiology and
pathogenesis, neurological disturbances, iron deficiency, and others. The two
most commonly used modes of therapy are pharmacological and nonpharmacological
therapy.
Global Restless Legs Syndrome Market: Competitive Insight
In order to study the
competition prevailing in the market, the report also profiles companies such
as GlaxoSmithKline plc., Kyowa Hakko Kirin Co., Boehringer Ingelheim GmbH, Jazz
Pharmaceuticals, Inc., and Manhattan Pharmaceuticals. The strengths and
weaknesses of the companies are weighed out in the report using SWOT analysis.
The analysis also helps the report gauge threats and opportunities that these
companies could face in the near future.
Request
A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12506
The report
offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market
size. The projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report serves
as a repository of analysis and information for every facet of the market,
including but not limited to: Regional markets, technology, types, and
applications.
About
Us
Transparency
Market Research (TMR) is a global market intelligence company providing
business information reports and services. The company’s exclusive blend of
quantitative forecasting and trend analysis provides forward-looking insight
for thousands of decision makers. TMR’s experienced team of analysts,
researchers, and consultants use proprietary data sources and various tools and
techniques to gather and analyze information.
TMR’s data
repository is continuously updated and revised by a team of research experts so
that it always reflects the latest trends and information. With extensive
research and analysis capabilities, Transparency Market Research employs
rigorous primary and secondary research techniques to develop distinctive data sets
and research material for business reports.
Contact us:
Mr. Sudip S
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email:Â sales@transparencymarketresearch.com
Comments